Suanfarma Suanfarma

X

Find Cebranopadol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Cebranopadol
Also known as: 863513-91-1, Grt6005, Grt-6005, Grt 6005, 863513-93-3, 7gdw9s3gn3
Molecular Formula
C24H27FN2O
Molecular Weight
378.5  g/mol
InChI Key
CSMVOZKEWSOFER-UHFFFAOYSA-N
FDA UNII
7GDW9S3GN3

Cebranopadol is an orally available benzenoid that acts as an opioid peptide receptor agonist for the nociceptin/orphanin FQ peptide receptor (opioid receptor like -1; OPRL1; ORL-1; NOP; kappa-type 3 opioid receptor) and the classical opioid receptors, mu, delta and kappa, with potential anti-nociceptive activity. Upon oral administration, cebranopadol binds to NOP and the mu, delta and kappa opioid receptors, which enhances NOP- and opioid receptor-mediated signaling, interferes with the sensation of pain and results in an analgesic effect. NOP, a member of the opioid receptor family, and its endogenous ligand nociceptin play key roles in the regulation of various brain activities including pain, and some inflammatory and immune responses.
1 2D Structure

Cebranopadol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-fluoro-N,N-dimethyl-1'-phenylspiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine
2.1.2 InChI
InChI=1S/C24H27FN2O/c1-27(2)23(17-6-4-3-5-7-17)11-13-24(14-12-23)22-19(10-15-28-24)20-16-18(25)8-9-21(20)26-22/h3-9,16,26H,10-15H2,1-2H3
2.1.3 InChI Key
CSMVOZKEWSOFER-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN(C)C1(CCC2(CC1)C3=C(CCO2)C4=C(N3)C=CC(=C4)F)C5=CC=CC=C5
2.2 Other Identifiers
2.2.1 UNII
7GDW9S3GN3
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 6'-fluoro-4',9'-dihydro-n,n-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'h)-pyrano(3,4-b)indol)-4-amine

2.3.2 Depositor-Supplied Synonyms

1. 863513-91-1

2. Grt6005

3. Grt-6005

4. Grt 6005

5. 863513-93-3

6. 7gdw9s3gn3

7. Cebranopadol ((1alpha,4alpha)stereoisomer)

8. 863513-91-1 (free Base)

9. (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine

10. 6-fluoro-n,n-dimethyl-1'-phenylspiro[4,9-dihydro-3h-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine

11. Spiro(cyclohexane-1,1'(3'h)-pyrano(3,4-b)indol)-4-amine, 6'-fluoro-4',9'-dihydro-n,n-dimethyl-4-phenyl-, Trans-

12. Trans-6'-fluoro-n,n-dimethyl-4-phenyl-4',9''-dihydro-3'h-spiro(cyclohexane-1,1'-pyrano(3,4-b)indol)-4-amine

13. 6-fluoro-n,n-dimethyl-1'-phenyl-spiro[4,9-dihydro-3h-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine

14. Cebranopadol [inn]

15. Cebranopadol [usan:inn]

16. Unii-7gdw9s3gn3

17. Cebranopadol (usan/inn)

18. Cebranopadol [usan]

19. Cebranopadol(grt-6005)

20. Schembl154336

21. Schembl566256

22. Gtpl8866

23. Chembl2364605

24. Chembl3545616

25. Chembl3962932

26. Schembl10035739

27. Schembl14183935

28. Schembl19336241

29. Bdbm177926

30. Dtxsid001031965

31. Bcp09612

32. Ex-a1095

33. Zinc3950145

34. Bdbm50101095

35. Bdbm50101112

36. Bdbm50533342

37. Akos025290738

38. Cs-1323

39. Db12830

40. Sb16531

41. Ncgc00378895-01

42. Ncgc00378895-02

43. Ac-36077

44. As-35183

45. Hy-15536

46. Ft-0774945

47. D10436

48. Us9120797, 24

49. Us9120797, 25

50. Q19596315

51. (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4-b]indole]-4-amine

2.4 Create Date
2006-11-06
3 Chemical and Physical Properties
Molecular Weight 378.5 g/mol
Molecular Formula C24H27FN2O
XLogP34.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass378.21074165 g/mol
Monoisotopic Mass378.21074165 g/mol
Topological Polar Surface Area28.3 Ų
Heavy Atom Count28
Formal Charge0
Complexity553
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of chronic pain


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY